"Lung Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the LUNG.
| Descriptor ID |
D008175
|
| MeSH Number(s) |
C04.588.894.797.520 C08.381.540 C08.785.520
|
| Concept/Terms |
Lung Neoplasms- Lung Neoplasms
- Pulmonary Neoplasms
- Neoplasms, Lung
- Lung Neoplasm
- Neoplasm, Lung
- Neoplasms, Pulmonary
- Neoplasm, Pulmonary
- Pulmonary Neoplasm
Lung Cancer- Lung Cancer
- Cancer, Lung
- Cancers, Lung
- Lung Cancers
- Pulmonary Cancer
- Cancer, Pulmonary
- Cancers, Pulmonary
- Pulmonary Cancers
- Cancer of the Lung
- Cancer of Lung
|
Below are MeSH descriptors whose meaning is more general than "Lung Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Lung Neoplasms".
This graph shows the total number of publications written about "Lung Neoplasms" by people in this website by year, and whether "Lung Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 10 | 2 | 12 |
| 1996 | 11 | 3 | 14 |
| 1997 | 10 | 2 | 12 |
| 1998 | 10 | 4 | 14 |
| 1999 | 13 | 0 | 13 |
| 2000 | 21 | 2 | 23 |
| 2001 | 11 | 7 | 18 |
| 2002 | 19 | 4 | 23 |
| 2003 | 24 | 7 | 31 |
| 2004 | 19 | 7 | 26 |
| 2005 | 22 | 1 | 23 |
| 2006 | 16 | 3 | 19 |
| 2007 | 28 | 6 | 34 |
| 2008 | 48 | 3 | 51 |
| 2009 | 23 | 7 | 30 |
| 2010 | 34 | 6 | 40 |
| 2011 | 43 | 8 | 51 |
| 2012 | 51 | 6 | 57 |
| 2013 | 33 | 5 | 38 |
| 2014 | 31 | 10 | 41 |
| 2015 | 49 | 8 | 57 |
| 2016 | 46 | 7 | 53 |
| 2017 | 45 | 8 | 53 |
| 2018 | 41 | 8 | 49 |
| 2019 | 47 | 5 | 52 |
| 2020 | 38 | 7 | 45 |
| 2021 | 46 | 2 | 48 |
| 2022 | 48 | 0 | 48 |
| 2023 | 37 | 0 | 37 |
| 2024 | 33 | 8 | 41 |
| 2025 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lung Neoplasms" by people in Profiles.
-
Safety and Tolerability of Letetresgene Autoleucel (GSK3377794): Pilot Studies in Patients with Advanced Non-Small Cell Lung Cancer. Clin Cancer Res. 2025 Feb 03; 31(3):529-542.
-
Alternative polyadenylation shapes the molecular and clinical features of lung adenocarcinoma. Hum Mol Genet. 2025 Jan 23; 34(1):1-10.
-
Real-time CBCT imaging and motion tracking via a single arbitrarily-angled x-ray projection by a joint dynamic reconstruction and motion estimation (DREME) framework. Phys Med Biol. 2025 Jan 21; 70(2).
-
Zongertinib (BI 1810631), an Irreversible HER2 TKI, Spares EGFR Signaling and Improves Therapeutic Response in Preclinical Models and Patients with HER2-Driven Cancers. Cancer Discov. 2025 Jan 13; 15(1):119-138.
-
Ongoing replication stress tolerance and clonal T cell responses distinguish liver and lung recurrence and outcomes in pancreatic cancer. Nat Cancer. 2025 Jan; 6(1):123-144.
-
Examining Lung Cancer Screening Uptake in the United States: Recent Research and Limitations of Public-Use Data. Cancer Epidemiol Biomarkers Prev. 2025 Jan 09; 34(1):9-11.
-
Robust Bayesian graphical regression models for assessing tumor heterogeneity in proteomic networks. Biometrics. 2025 Jan 07; 81(1).
-
Occult metastases and survival of lung cancer by clinical diagnosis and CT screening: A simulation study. PLoS One. 2025; 20(1):e0313544.
-
Complement factor H targeting antibody GT103 in refractory non-small cell lung cancer: a phase 1b dose escalation trial. Nat Commun. 2025 Jan 02; 16(1):93.
-
Sensitivity to Environmental Stress and Adversity and Lung Cancer. JAMA Netw Open. 2025 Jan 02; 8(1):e2457079.